Skip to main content

Literature Review

First Report Managed Care
Per the American Migraine foundation, oral and intranasal triptan therapy has proven consistently effective when used to treat migraine earlier in the attack, however, triptan therapy is not effective for all patients with migraine and cannot prevent or stop every headache
First Report Managed Care
Currently, chimeric antigen receptor T-cell (CAR-T) therapies are regulated as drugs—often leading to higher prices and barriers to access for patients, as well as financial strains for hospitals. However, in a recent insights article in JAMA Health Forum, researchers examine if CAR-T therapies can…
Pharmacy Learning Network
A Class II recall is active for a prescription analgesic injection used during anesthetic periods, premedication, induction and maintenance, and in the immediate postoperative period.
First Report Managed Care
With the advent of calcitonin gene-related peptide (CGRP) inhibitors, which are either monoclonal antibodies or CGRP receptor agonists that block CGRP proteins in the head and neck, another treatment option has emerged for patients where other therapies have failed.
First Report Managed Care
Although hemophilia is designated an orphan disease by the FDA because it affects fewer than 200,000 people in the United States, it imposes a significant financial and burden on patients, caregivers, and society.
First Report Managed Care
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
First Report Managed Care
Rheumatoid arthritis (RA) continues to affect as many as 1.5 million adults in the United States.
First Report Managed Care
Neuroendocrine tumors (NETs) are thought to arise from cells throughout the diffuse endocrine system. According to a report published in JAMA Oncology, the incidence and prevalence of NETS are steadily rising, though for reasons not well understood.
Back to Top